Skip to content
10-Q

Quarterly Report

NEUROCRINE BIOSCIENCES INC NBIX

0000914475-25-000181

← back to feed
Filed
Oct 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 21, 2025 99.71M sh
Shares Diluted Q3 2025 · Sep 30, 2025 102.5M sh
Shares Diluted Q3 2025 · Sep 30, 2025 102M sh
Shares Diluted Q3 2025 · Sep 30, 2024 104.3M sh
Shares Diluted Q3 2025 · Sep 30, 2024 104M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $167.7M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $36.4M
Capex Q3 2025 · Sep 30, 2024 $30.9M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $394.3M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $352.9M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $340.2M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $233M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $349.1M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3B
Stockholders Equity Q3 2025 · Jun 30, 2025 $2.69B
Stockholders Equity Q3 2025 · Dec 31, 2024 $2.59B
Stockholders Equity Q3 2025 · Sep 30, 2024 $2.72B
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.51B
Stockholders Equity Q3 2025 · Dec 31, 2023 $2.23B
Current Liabilities Q3 2025 · Sep 30, 2025 $638M
Current Liabilities Q3 2025 · Dec 31, 2024 $507.7M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.26B
Total Liabilities Q3 2025 · Dec 31, 2024 $1.13B
Current Assets Q3 2025 · Sep 30, 2025 $2.16B
Current Assets Q3 2025 · Dec 31, 2024 $1.72B
Total Assets Q3 2025 · Sep 30, 2025 $4.27B
Total Assets Q3 2025 · Dec 31, 2024 $3.72B
Eps Diluted Q3 2025 · Sep 30, 2025 $2.04
Eps Diluted Q3 2025 · Sep 30, 2025 $3.19
Eps Diluted Q3 2025 · Sep 30, 2024 $1.24
Eps Diluted Q3 2025 · Sep 30, 2024 $2.29
Eps Basic Q3 2025 · Sep 30, 2025 $2.11
Eps Basic Q3 2025 · Sep 30, 2025 $3.27
Eps Basic Q3 2025 · Sep 30, 2024 $1.28
Eps Basic Q3 2025 · Sep 30, 2024 $2.37
Sga Expense Q3 2025 · Sep 30, 2025 $291.6M
Sga Expense Q3 2025 · Sep 30, 2025 $854.4M
Sga Expense Q3 2025 · Sep 30, 2024 $234.3M
Sga Expense Q3 2025 · Sep 30, 2024 $719.4M
Net Income Q3 2025 · Sep 30, 2025 $209.5M
Net Income Q3 2025 · Sep 30, 2025 $324.9M
Net Income Q3 2025 · Sep 30, 2024 $129.8M
Net Income Q3 2025 · Sep 30, 2024 $238.2M
Operating Income Q3 2025 · Sep 30, 2025 $239M
Operating Income Q3 2025 · Sep 30, 2025 $408.2M
Operating Income Q3 2025 · Sep 30, 2024 $183.8M
Operating Income Q3 2025 · Sep 30, 2024 $428.5M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $14M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $34.5M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $8M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $24.7M
Revenue Q3 2025 · Sep 30, 2025 $794.9M
Revenue Q3 2025 · Sep 30, 2025 $2.06B
Revenue Q3 2025 · Sep 30, 2024 $622.1M
Revenue Q3 2025 · Sep 30, 2024 $1.73B